Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Actiphage detects Johne’s disease in vaccinated goat

A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the potential for a vaccination programme.
  • June 9, 2022
  • goats, MAP

New research shows potential of Actiphage to differentiate vaccinated from infected animals (DIVA test)

Vaccination of livestock against Johne’s Disease has been hindered by the lack of a diagnostic that can differentiate vaccinated from infected animals (DIVA test).

Now a study presented at ICP 2022 has shown that the blood test Actiphage® is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the potential for a vaccination programme.

Existing tests use immune response

Most existing Johne’s tests rely on an animal’s immune response, which develops only as the disease progresses. These tests cannot be used to detect infection in vaccinated animals because if the vaccine has worked, they will automatically give a positive test result. In contrast, Actiphage detects live bacteria in a milk or blood sample and so is not affected by the vaccination status of the animal.

However, Actiphage was originally developed to detect MAP inside the white blood cells of cattle, so it requires optimising for goats, as the properties of blood from other species of animals can be quite different.

Professor Cath Rees of the University of Nottingham has been experimenting with three methods of sample preparation in order to optimise the technique for different host species and she presented the findings in a poster at ICP 2022 Dublin.

Three different techniques of sample preparation were used to separate out the white blood cells: Ficoll density gradients, which takes advantage of the density differences between white blood cells and other types of blood cell; differential lysis using Ammonium Chloride-Potassium (ACK), which lyses the red blood cells, leaving white blood cells intact; and enhanced sedimentation, which causes the red blood cells to separate out under gravity, leaving the white blood cells behind.

Professor Rees, who is also CSO of PBD Biotech, said: “We have now shown that Actiphage is compatible with a range of different methods for purifying white blood cells, demonstrating the versatility of our test and opening up a number of new applications.”

The study found that it was important to select the right method for the host species to optimise the process. Blood samples from domestic goats (caprine) were first tested using Ficoll, the standard Actiphage method used for cattle, which was then optimised for caprine white blood recovery by using the ACK lysis method.

Once the blood cells are isolated, Actiphage is used to extract the DNA from MAP cells for identification using PCR. In cattle the primers P90 and P91 are used to bookend the target region on the DNA that needs to be copied. However, analysis showed the genomes of strains of MAP found in goats were different, so the primers were redesigned to improve sensitivity for MAP detection in goat blood.

The optimised Actiphage assay was used to screen caprine blood samples of known ELISA status. 60% of ELISA-positive animals gave a positive Actiphage test result, confirming the infection status of these animals.

Detects live MAP in vaccinated goat

Interestingly, in one set of vaccinated goats, Actiphage also detected viable MAP in the blood samples from one animal, indicating that this animal was infected despite vaccination.

Professor Rees commented: “This study provides evidence that Actiphage can also be used as a DIVA test, allowing us to differentiate between naturally infected and vaccinated animals; this will support the use of vaccines as part of MAP control programs.”

Share:

Related posts

Loading...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to talk about our new blood test and bulk milk test with producers, cheesemakers, dairy companies and others across the industry...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to...
Actiphage use as a DIVA test

Actiphage optimised to detect MAP in humans and to support use as ‘DIVA’

June 1, 2022
This is the first time Actiphage has been used to detect MAP in a human blood sample and also to identify a live infection in a vaccinated goat.
Actiphage use as a DIVA test

Actiphage optimised to detect MAP in humans and to support use as ‘DIVA’

June 1, 2022
This is the first time Actiphage has been used to detect MAP in a human blood sample and also to...
bison MAP diagnostic

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria in blood.
bison MAP diagnostic

Actiphage identifies strain of mycobacteria in blood of bison

May 26, 2022
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria...
Johnes Disease testing service

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022
PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the cause of Johne's Disease
Johnes Disease testing service

7th April 2022, Stoneleigh Park, CV8 2LH

Dairy-Tech 2022 PBD Biotech to launch new Johne’s Disease testing service

April 1, 2022
PBD Biotech to launch at Dairy-Tech, a new rapid test that will enable farmers to find out in days if...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More